Can axillary dissection be avoided by improved molecular biological diagnosis? - Test2 - elhamkhani - TriplyDB

Can axillary dissection be avoided by improved molecular biological diagnosis?

Can axillary dissection be avoided by improved molecular biological diagnosis?

http://www.wikidata.org/entity/Q34033291

about

Methylation signature of lymph node metastases in breast cancer patients Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.

P2860

Q34303360-659F7F58-C1A2-47CC-A55F-FADB914D56EC Q34696134-36AADC09-B963-40D6-902D-2EA526D3489B

P2860

Can axillary dissection be avoided by improved molecular biological diagnosis?

http://www.wikidata.org/entity/Q34033291

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

name

Can axillary dissection be avoided by improved molecular biological diagnosis?

@ast

Can axillary dissection be avoided by improved molecular biological diagnosis?

@en

Can axillary dissection be avoided by improved molecular biological diagnosis?

@nl

type

label

Can axillary dissection be avoided by improved molecular biological diagnosis?

@ast

Can axillary dissection be avoided by improved molecular biological diagnosis?

@en

Can axillary dissection be avoided by improved molecular biological diagnosis?

@nl

prefLabel

Can axillary dissection be avoided by improved molecular biological diagnosis?

@ast

Can axillary dissection be avoided by improved molecular biological diagnosis?

@en

Can axillary dissection be avoided by improved molecular biological diagnosis?

@nl

P1433

Q34033291-E6AFBE5B-510D-436C-B74B-5768D30035A7

P1476

Q34033291-D5015D16-4D38-46C4-904C-21C60B558315

P2093

Q34033291-0D3FC993-C9D1-40C7-BF0E-9D90CA470741

Q34033291-1E0A767E-8116-425B-BAED-D1EAE4F32AD5

Q34033291-21CC5DE2-5B7E-4C36-A4E8-6B55EE00A993

Q34033291-277DD32B-31BD-4E3C-B28F-6D8A3244CEED

Q34033291-3C14ED94-75D4-4F0F-874D-B6906D0549B9

Q34033291-E990EB36-4492-4C15-B0CA-773696C3B610

Q34033291-EA4694D0-E379-4CC6-A568-820D59AC4655

Q34033291-FCC922C8-FC55-4D11-B13E-370E33DC76EE

P2860

Q34033291-0372333E-6AF4-4610-86C7-55033EC0BF5D

Q34033291-08C20E2E-BB42-41E6-9522-1EC980C9CA07

Q34033291-11FD3A6B-78B6-4BE0-A29A-505AAA909322

Q34033291-16392CB4-E1C9-463C-8502-C5CCC4CE8FA0

Q34033291-1E2ECFEF-C4F6-4336-A5EA-D820C497BA0F

Q34033291-204146F2-B833-4BC8-86CC-E10E3D8A9CCA

Q34033291-244005BE-CDDF-4151-A295-BE3BB3D43CF5

Q34033291-2F8949D4-C50F-402F-8EF6-7544300E0ABC

Q34033291-362B4949-A18E-4598-925D-4DF07674DCA0

Q34033291-36E86B24-10A4-4C2A-87C7-A8B26241903A

P304

Q34033291-74DFCCB1-1814-4778-AF89-D17875B36C13

P31

Q34033291-72515DE0-00EA-46D8-96FF-C4E27AC731B3

P356

Q34033291-47C8E1B5-0E5A-4C99-B078-49EA2718CDFB

P433

Q34033291-49D1798F-5425-45AA-81C2-949004F363D4

P478

Q34033291-34F26464-3076-4EFA-9976-C2B1FAFD8077

P50

Q34033291-CFDC8E90-9296-4AAF-BC6E-7A6CF8CC9343

P577

Q34033291-FD7019CF-3828-4CF0-B88C-15B507C1A47C

P5875

Q34033291-73ABF93B-A220-4B7B-99BB-42D938323AD5

P698

Q34033291-EE0A1B9C-4168-4A3D-92F1-A54EF64E500E

P356

028418600750013087

P1433

Acta Oncologica

P1476

Can axillary dissection be avoided by improved molecular biological diagnosis?

@en

P2093

Ahlgren J

http://www.w3.org/2001/XMLSchema#string

Andersson J

http://www.w3.org/2001/XMLSchema#string

Bergh J

http://www.w3.org/2001/XMLSchema#string

Bjöhle J

http://www.w3.org/2001/XMLSchema#string

Engel G

http://www.w3.org/2001/XMLSchema#string

Klaar S

http://www.w3.org/2001/XMLSchema#string

Lindman H

http://www.w3.org/2001/XMLSchema#string

von Schoultz E

http://www.w3.org/2001/XMLSchema#string

P2860

High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer.

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

Assessment of morbidity from complete axillary dissection.

Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study.

P304

319-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/028418600750013087

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270613513

http://www.w3.org/2001/XMLSchema#string

P698

10987228

http://www.w3.org/2001/XMLSchema#string